MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

08 Mar 2022 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company's joint venture, Aleor Dermaceuticals has received US Food and Drug Administration (USFDA) Final Approval for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/gram. In this regard, the company has enclosed a press release.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..